PARAMETRIC PORTFOLIO ASSOCIATES LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$5,669,000
+32.2%
251,740
+16.2%
0.00%
+50.0%
Q4 2021$4,288,000
-13.5%
216,574
-14.1%
0.00%
-33.3%
Q3 2021$4,960,000
+2.1%
252,012
+14.1%
0.00%0.0%
Q2 2021$4,859,000
-13.7%
220,846
-6.7%
0.00%0.0%
Q1 2021$5,633,000
-6.3%
236,764
+3.1%
0.00%
-25.0%
Q4 2020$6,010,000
+38.9%
229,746
-7.6%
0.00%
+33.3%
Q3 2020$4,328,000
+19.9%
248,638
+15.8%
0.00%0.0%
Q2 2020$3,611,000
+55.9%
214,656
+10.2%
0.00%
+50.0%
Q1 2020$2,316,000
+25.8%
194,747
+28.0%
0.00%
+100.0%
Q4 2019$1,841,000
+12.0%
152,182
+30.9%
0.00%0.0%
Q3 2019$1,644,000
+87.7%
116,295
+47.9%
0.00%0.0%
Q2 2019$876,000
-51.3%
78,607
-48.7%
0.00%
-50.0%
Q1 2019$1,800,000
-25.7%
153,337
-15.5%
0.00%0.0%
Q4 2018$2,423,000
+13.7%
181,379
+19.3%
0.00%0.0%
Q3 2018$2,131,000
-13.3%
151,984
-2.8%
0.00%0.0%
Q2 2018$2,458,000
-25.2%
156,368
-21.7%
0.00%
-33.3%
Q1 2018$3,286,000
+12.9%
199,745
+23.9%
0.00%0.0%
Q4 2017$2,911,000
+4.2%
161,197
+11.4%
0.00%0.0%
Q3 2017$2,794,000
+159.2%
144,764
+58.4%
0.00%
+200.0%
Q2 2017$1,078,000
+129.9%
91,383
+113.6%
0.00%0.0%
Q1 2017$469,000
+40.0%
42,791
-7.3%
0.00%
Q4 2016$335,000
+238.4%
46,175
+204.6%
0.00%
Q3 2016$99,000
+33.8%
15,157
+11.1%
0.00%
Q2 2016$74,000
+21.3%
13,640
+4.4%
0.00%
Q1 2016$61,000
+7.0%
13,065
+14.3%
0.00%
Q4 2015$57,000
+35.7%
11,427
+2.7%
0.00%
Q3 2015$42,000
-59.6%
11,126
-35.6%
0.00%
Q2 2015$104,000
-66.8%
17,270
-69.1%
0.00%
-100.0%
Q1 2015$313,000
+86.3%
55,955
+0.1%
0.00%
Q4 2014$168,000
+13.5%
55,919
+1.2%
0.00%
Q3 2014$148,000
+14.7%
55,256
+87.0%
0.00%
Q1 2014$129,000
+35.8%
29,5550.0%0.00%
Q4 2013$95,000
+156.8%
29,555
+26.2%
0.00%
Q3 2013$37,000
-30.2%
23,416
-23.4%
0.00%
Q2 2013$53,00030,5810.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders